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Subsequent to the publication of the above article, the authors have realized that [Fig. 2](#f2-mmr-19-03-1979){ref-type="fig"} in their paper contained an error. The image selected to represent the experiment showing the migration of cells in the presence of andrographolide (30 μM) was chosen incorrectly during the figure compilation process. A corrected version of [Fig. 2](#f2-mmr-19-03-1979){ref-type="fig"} is presented here. Note that this change does not affect the results or the conclusions reported in this paper, and all the authors agree to this correction.

The authors apologize to the Editor and to the readership of the Journal for any inconvenience caused.

![Andrographolide (AP) inhibits MDA-MB-231 breast cancer cell invasion and migration in a concentration-dependent manner at sub-lethal concentrations *in vitro*. (A) Membrane-associated, Liu-stained MDA-MB-231 breast cancer cells following treatment with AP and PMA. The numbers of (B) migrated and (C) invasive cells were counted. Results were recorded at least three times in three independent experiments and are presented as the mean ± standard deviation, n=3. \*P\<0.05 and \*\*P\<0.01.](MMR-19-03-1979-g00){#f2-mmr-19-03-1979}
